
Acasti Pharma (ACST) Stock Forecast & Price Target
Acasti Pharma (ACST) Analyst Ratings
Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 29%
Hold 29%
Sell 0%
Strong Sell 0%
Acasti Pharma (ACST) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Acasti Pharma and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Acasti Pharma and is not a guaranteed prediction by Public.com or investment advice.
Acasti Pharma (ACST) Analyst Forecast & Price Prediction
Get the latest Acasti Pharma (ACST) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Acasti Pharma (ACST)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Acasti Pharma (ACST) Forecast
Analysts have given Acasti Pharma (ACST) a Buy based on their latest research and market trends.
According to 7 analysts, Acasti Pharma (ACST) has a Buy consensus rating as of Jun 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $5.18, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $5.18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.